Executive Summary
This procedural order from the UPC Court of Appeal addressed Alexion Pharmaceuticals' appeal against a prior decision concerning provisional measures. The core issue was Alexion's request for an expedited hearing, arguing that the matter was purely legal and required swift resolution. The Court ultimately rejected this request, emphasizing the need to balance due process with the respondent's interests, thereby maintaining standard procedural timelines.
What the Court Held — Ratio Decidendi
The Court of Appeal held that the circumstances were not sufficiently urgent to warrant shortening the time limit for lodging a statement of response, balancing due process principles with the interests of both parties. The court noted that the existing 15-day period was already relatively short for appeals against orders referred to in R. 220.1(c) RoP.
Practitioner Note
This case demonstrates the evidentiary and procedural standards applied in patent matters before Luxembourg (LU). Understanding the court's reasoning in Alexion Pharmaceuticals, Inc. vs Samsung Bioepis NL B.V. is valuable context for structuring arguments or assessing risk in similar proceedings.
Related Cases
Belparts Group N.V.vsIMI Hydronic International SA; IMI Hydronic Engineering AB
Belparts Group N.V. sought to consolidate its current infringement action with a parallel counterclaim pending before the Central Division Paris, arguing for consistent application of UPC law. Although IMI consented to the consolidation, the Local Division Munich dismissed the request. The Court found that since the proceedings were lodged in different divisions (Local vs. Central), the statutory requirement under R. 302.3 RoP was not satisfied.
Atlas Global Technologies GmbHvsVantiva SA
In a procedural decision, the Düsseldorf Local Division accepted the withdrawal of an infringement claim brought by Atlas Global Technologies GmbH against Vantiva SA and its affiliates. Concurrently, the counterclaim seeking revocation of EP 3186937 was also withdrawn. The court formally terminated both proceedings based on the parties' mutual agreement. This case highlights how procedural agreements between litigants can lead to the early conclusion of complex UPC actions.
Guardant Health, Inc.vsSophia Genetics SA, Sophia Genetics SAS, Sophia Genetics SRL, Sophia Genetics GmbH
This UPC Court of Appeal decision addressed an application for suspensive effect filed by Guardant Health against Sophia Genetics concerning a provisional measures proceeding. Guardant sought to suspend the interim award of EUR 400,000 in costs granted by the Court of First Instance (CFI). The court ultimately rejected this request, holding that the appeal lacked the necessary exceptional circumstances to override the general rule that appeals do not have suspensive effect. This case reinforces the strict procedural requirements for obtaining suspensive effect in UPC proceedings.
PAPST LICENSING GmbH & Co. KGvsEcovacs Home Service Robotics Co.,Ltd.
In this procedural order concerning a patent infringement case involving Ecovacs and Papst Licensing, the UPC Local Division Munich addressed a request for deadline extensions by one of the defendants. The court ultimately rejected the motion, finding that the defendant's primary motivation was procedural simplification rather than an urgent need to prepare its defense. This decision highlights the Court's focus on balancing procedural efficiency with the claimant's interests in maintaining timely proceedings.
bellissa HAAS GmbHvsWindhager Handelsgesellschaft m.b.H.
This UPC Court of Appeal decision addressed Windhager's request to stay the execution of a judgment issued by the Local Division in an infringement case against bellissa HAAS GmbH. Although Windhager had raised revocation defenses, the court found insufficient grounds to grant the stay. The ruling reinforces the high threshold required for obtaining a stay of execution under UPC rules, emphasizing that mere allegations of error are not enough.
Dealing with a patent challenge?
Whether it's a Section 3(d) rejection, a post-grant opposition, or a FRAND dispute, Arctic's patent litigation team has handled it. Get a strategy call.
Disclaimer: This page contains an automated summary based on publicly available judicial records. The content is generated for informational purposes only and does not constitute legal advice. Always verify details against the original source judgment before relying on this information for any legal purpose. If you believe any information is inaccurate, please contact us.